ClearPoint Neuro (CLPT) Capital Expenditures Growth (1y) (2012 - 2026)
ClearPoint Neuro (CLPT) Capital Expenditures Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.21 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.52 Bn | 125.64 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 108.06 Bn | 98.84 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 68.04 Bn | 66.59 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 15.89% |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | 106.98% |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | -11.95% |
| 8 | Smith & Nephew | 26.88 Bn | 26.30 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | -47.73% |
| 10 | ClearPoint Neuro | 426.44 Mn | 390.84 Mn | 7.76 Mn | 252.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 252.46% |
| Dec 31, 2025 | -81.37% |
| Sep 30, 2025 | 1,558.33% |
| Dec 31, 2024 | 1,152.38% |
| Sep 30, 2024 | -94.89% |
| Dec 31, 2023 | -46.15% |
| Sep 30, 2023 | 240.58% |
| Jun 30, 2023 | 325.00% |
| Mar 31, 2023 | 100.00% |
| Dec 31, 2022 | 2.63% |
| Sep 30, 2022 | -44.80% |
| Jun 30, 2022 | 317.14% |
| Mar 31, 2022 | 72.50% |
| Dec 31, 2019 | -122.65% |
| Mar 31, 2016 | 1,070.29% |
| Sep 30, 2015 | 940.63% |
| Jun 30, 2015 | -75.17% |
| Mar 31, 2015 | 177.62% |
| Dec 31, 2014 | 4,334.34% |
| Sep 30, 2014 | -65.10% |